Look for:

Our offer for

BAYER AG


ISIN:
DE000BAY0017
WKN:
BAY001

2024/09/18 16:15:09
Price
27.865 EUR
Difference 1.98% (0.54)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeStuttgart
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)26,982 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)27.875 EUR (4,305)
Ask (Ask size)27.875 EUR (4,305)
Open27.33 EUR
High27.875 EUR
Low27.33 EUR
Close (prev. day)27.325 EUR
VWAP-
Volume (pcs)20,077
Trading volume553,971.13
Number of trades135
Last size0

Futures and Options

Related Futures54
Related Options-

PDF Downloads

Company report: BAYER AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/09/18 16:15:09
Price
27.865 EUR
Difference 1.98% (0.54)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeStuttgart
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)26,982 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)27.875 EUR (4,305)
Ask (Ask size)27.875 EUR (4,305)
Open27.33 EUR
High27.875 EUR
Low27.33 EUR
Close (prev. day)27.325 EUR
VWAP-
Volume (pcs)20,077
Trading volume553,971.13
Number of trades135
Last size0

Performance and Risk

6m1Y3Y
Perf (%)+4.37%-44.65%-39.78%
Perf (abs.)+1.15-22.04-18.05
Beta---
Volatility30.1034.7830.19
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)27.005 EUR (28,736)
Ø price 30 days | Ø volume 30 days (pcs.)27.434 EUR (30,314)
Ø price 100 days | Ø volume 100 days (pcs.)27.309 EUR (26,917)
Ø price 250 days | Ø volume 250 days (pcs.)30.801 EUR (47,743)
YTD High | date36.055 EUR (2024/01/08)
YTD Low | date24.985 EUR (2024/03/07)
52 Weeks High | date49.525 EUR (2023/09/18)
52 Weeks Low | date24.985 EUR (2024/03/07)

All listings for BAYER AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/09/1815:3627.805 EUR0.0013
Bucharest Stock Exchange2024/09/1816:13137.20 RON0.045
Budapest Stock Exchange2024/09/1813:3510,848.00 HUF0.271
Duesseldorf2024/09/1812:3127.40 EUR0.003
Euronext Milan MTF Global Equity Market2024/09/1816:1527.84 EUR0.46118
Euronext Milan MTF Trading After Hours2024/09/1618:3627.10 EUR0.001
FINRA other OTC Issues2024/09/1621:4929.90 USD0.056
Frankfurt2024/09/1816:1027.87 EUR0.0717
Hamburg2024/09/1815:0127.715 EUR0.083
Hanover2024/09/1808:1627.465 EUR0.001
London Stock Exchange European Trade Reporting2024/09/1813:4927.50 EUR1.652
Munich2024/09/1808:0427.425 EUR0.001
SIX Swiss Exchange2024/06/1417:35179.00 CHF0.001
SIX Swiss Exchange2023/02/2117:3560.00 EUR0.001
Stuttgart2024/09/1816:1527.865 EUR0.55135
Tradegate2024/09/1816:1527.86 EUR2.31433
Vienna Stock Exchange2024/09/1815:3027.785 EUR0.015
Xetra2024/09/1816:1527.87 EUR30.594,440

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=958&ID_TYPE_IMAGE_LOGO=2

Contact Details

BAYER AG
- -
Kaiser-Wilhelm-Allee 1 - 51368 Leverkusen
Telefon: +49-214-30-1
Fax: +
E-mail: -

PDF Downloads

Company report: BAYER AGPDF Download

Company Profile

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and womenšs health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Members of Management Board

B. Chuck AndersonChairman of Managing Board
Heike PrinzMember of Executive Committee
Julio TrianaMember of Executive Committee
Rodrigo SantosMember of Executive Committee
Stefan OelrichMember of Executive Committee
Wolfgang NicklMember of Executive Committee

Board of directors

Norbert WinkeljohannChairman of Supervisory Board
Barbara GansewendtMember of Supervisory Board
Ertharin CousinMember of Supervisory Board
Nancy SimonianMember of Supervisory Board
Paul AchleitnerMember of Supervisory Board
Alberto WeisserMember of Supervisory Board
Andrea SacherMember of Supervisory Board
André van BroichMember of Supervisory Board
Claudia SchadeMember of Supervisory Board
Colleen GogginsMember of Supervisory Board
Francesco GrioliMember of Supervisory Board
Frank LöllgenMember of Supervisory Board
Heike HausfeldMember of Supervisory Board
Heinz Georg WebersMember of Supervisory Board
Horst Heinz Paul BaierMember of Supervisory Board
Jeffrey UbbenMember of Supervisory Board
Kimberly Marie Lein-MathisenMember of Supervisory Board
Lori SchechterMember of Supervisory Board
Michael WestmeierMember of Supervisory Board
Yasmin FahimiMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer